Surgery, kinetics and biological considerations in planning adjuvant therapy protocols.
Forbes
J F
JF
University of Newcastle, Mater Misericordiae Hospital, Waratah, N.S.W., Australia.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D002455:Cell Division / Q000502:physiology; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007700:Kinetics; D009362:Neoplasm Metastasis / Q000276:immunology / Q000503:physiopathology*; D011960:Receptors, Estrogen / Q000502:physiology; D013514:Surgical Procedures, Operative / Q000009:adverse effects
D011960:Receptors, Estrogen